Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pfizer (NY: PFE ) 28.64 -0.03 (-0.10%) Streaming Delayed Price Updated: 11:34 AM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Pfizer < Previous 1 2 3 4 5 6 7 8 9 ... 99 100 Next > Warren Buffett's Approach To Investing In Election Years August 07, 2024 Warren Buffett, known as the 'Oracle of Omaha', is a highly successful American investor who manages his portfolio consistently, regardless of elections or market conditions. Via Benzinga BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Release Promising Clinical Data As Global Alzheimer’s Disease Therapeutics Market Grows August 07, 2024 Via Investor Brand Network Forget Tech! 3 Value Stocks That Could Win Big From Rate Cuts. August 07, 2024 Several value stocks are poised to benefit richly from upcoming rate cuts that could happen as soon as September when the Fed reconvenes. Via InvestorPlace Topics Economy Exposures Interest Rates 3 Dividend Growth Stocks to Buy Hand Over Fist in August August 07, 2024 There are blue-chip bargains paying large and growing dividends in the healthcare space. Via The Motley Fool Is Pfizer Winning Its $43 Billion Bet? August 02, 2024 Pfizer's efforts are starting to bear fruit. Via The Motley Fool Lucrative Incentive for Biotechs as Global Alzheimer’s Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033 August 06, 2024 EQNX::TICKER_START (NYSE:ANVS),(NYSE:PFE),(NYSE:LLY),(NYSE:GSK),(NYSE:NVO) EQNX::TICKER_END Via FinancialNewsMedia 3 Cheap Stocks to Buy in August for Under $50 August 06, 2024 It is never too early or too late to start investing, so choose these cheap stocks under $50 to start building your portfolio. Via InvestorPlace 3 Unstoppable Dividend Stocks Yielding More Than 4% for Income-Seeking Investors to Buy in August and Hold Forever August 06, 2024 The dividend payments you can receive from these high-yield stocks are yours to keep, regardless of a market correction. Via The Motley Fool Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033 August 06, 2024 From FN Media Group LLC Via GlobeNewswire Is It Too Late to Buy Vertex Pharmaceuticals Stock? August 06, 2024 Shares of the rare disease drugmaker are already up more than 40% over the past year. Via The Motley Fool Volatility Spikes: 3 Low Beta Stocks To Buy August 06, 2024 Over recent months, several low-beta stocks have enjoyed positive earnings estimate revisions. For those looking for a higher level of defense, let’s take a closer look at each. Via Talk Markets Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data August 05, 2024 Nuvation Bio halts its NUV-868 BET inhibitor program after Phase 1 study analysis. The decision impacts solid tumor treatments in ovarian, pancreatic, and mCRPC cancers, focusing instead on late-stage... Via Benzinga Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again. August 05, 2024 Moderna sustained a rare downgrade on Monday following its guidance cut for the year. Via Investor's Business Daily BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products August 05, 2024 BioNTech posted a significant Q2 2024 loss of 807.8 million euros. Sales dropped to 128.7 million euros as the demand for COVID-19 vaccines shifted. R&D expenses rose due to late-stage oncology... Via Benzinga Exposures COVID-19 Investing $100,000 in These 7 High-Yield Dividend Stocks Could Generate Over $7,000 in Annual Passive Income August 04, 2024 Making passive income should be easy with these great stocks. Via The Motley Fool 2 Ultra-High-Yield Dividend Stocks to Buy in August and Hold at Least a Decade August 03, 2024 With an average yield above 7% at recent prices, these stocks could give your passive income stream a big boost. Via The Motley Fool Is This Decision by Pfizer Bad News for Eli Lilly? August 03, 2024 Lilly's revenue gains have helped its stock to roar higher. Via The Motley Fool Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer August 02, 2024 Moderna cuts its 2024 sales forecast due to weaker demand for COVID-19 vaccines. Sales now expected between $3B-$3.5B, down from $4B. Analysts adjust price targets, citing competitive pressures from... Via Benzinga Exposures COVID-19 What Are the Hottest Biotech Stocks Right Now? 3 Top Picks. August 02, 2024 Figuring out the hottest biotech stocks can be as simple as looking at the most traded stocks by volume in the last 24 hours. Via InvestorPlace Stock Market Takes Bearish Turn; Apple, Microsoft, Meta, Amazon, AMD In Focus: Weekly Review August 02, 2024 Apple and Meta had strong results, while AI spending remains robust. Via Investor's Business Daily Topics Artificial Intelligence Exposures Artificial Intelligence 7 Subdued Blue-Chip Stocks That Will Reward Patient Investors August 02, 2024 These are the blue-chip stocks to buy as they represent companies with strong fundamentals and growth acceleration possibility. Via InvestorPlace Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now. August 02, 2024 The popularity surrounding weight loss drugs such as Mounjaro and Ozempic has brought Eli Lilly and Novo Nordisk newfound growth. Via The Motley Fool Bargain-Hunters Paradise: 7 Value Stocks That Are Too Cheap to Ignore August 01, 2024 These cheap value stocks are priced right for any bargain hunters seeking deals in the market at the moment. Via InvestorPlace Phio Pharmaceuticals Announces New Chief Financial Officer August 01, 2024 Marlborough, Massachusetts--(Newsfile Corp. - August 1, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary... Via Newsfile Topics Initial Public Offering Exposures Securities Market Moderna Slashes Its Outlook On 'Very Low' European Sales Despite Quarterly Beat August 01, 2024 Moderna delivered nearly double the sales analysts expected in the second quarter. Via Investor's Business Daily Pfizer Just Confirmed It's a Dividend Investor's Dream Stock August 01, 2024 This big pharma stock gives investors juicy and reliable dividends plus the potential for future growth. Via The Motley Fool Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening August 01, 2024 Pfizer's debt load could inhibit the company's ability to take on acquisitions in the near term. Via The Motley Fool Pfizer Just Did This for the First Time in 6 Quarters. Time to Buy? August 01, 2024 Pfizer shares have advanced 20% over the past three months. Via The Motley Fool The Top 7 Stocks to Buy Now: Summer 2024 July 31, 2024 Investors should give consideration to taking a position in one of these top stocks to buy that are flashing strong growth signals. Via InvestorPlace Pfizer's Diverse Portfolio And Strong Execution Earn Analyst Praise Despite Patent Concerns July 31, 2024 Pfizer reported second-quarter adjusted EPS of $0.60, surpassing the consensus of $0.46. Sales reached $13.28 billion, beating expectations. Analysts highlight Pfizer's robust portfolio, effective... Via Benzinga Topics Intellectual Property Exposures Intellectual Property < Previous 1 2 3 4 5 6 7 8 9 ... 99 100 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.